Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.
Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan.
Ann Clin Transl Neurol. 2021 Nov;8(11):2121-2131. doi: 10.1002/acn3.51467. Epub 2021 Oct 15.
Mutations in the colony-stimulating factor 1 receptor gene (CSF1R) were identified as a cause of adult-onset inherited leukoencephalopathy. The present study aims at investigating the frequency, clinical characteristics, and functional effects of CSF1R mutations in Taiwanese patients with adult-onset leukoencephalopathy.
Mutational analysis of CSF1R was performed in 149 unrelated individuals with leukoencephalopathy by a targeted resequencing panel covering the entire coding regions of CSF1R. In vitro analysis of the CSF1-induced autophosphorylation activities of mutant CSF1R proteins was conducted to assess the pathogenicity of the CSF1R mutations.
Among the eight CSF1R variants identified in this study, five mutations led to a loss of CSF1-induced autophosphorylation of CSF1R proteins. Four mutations (p.K586*, p.G589R, p.R777Q, and p.R782C) located within the tyrosine kinase domain of CSF1R, whereas the p.T79M mutation resided in the immunoglobulin-like domain. The five patients carrying the CSF1R mutations developed cognitive decline at age 41, 43, 50, 79, and 86 years, respectively. Psychiatric symptoms and behavior changes were observed in four of the five patients. The executive function and processing speed were severely impaired at an early stage, and their cognitive function deteriorated rapidly within 3-4 years. Diffusion-restricted lesions at the subcortical regions and bilateral corticospinal tracts were found in three patients.
CSF1R mutations account for 3.5% (5/149) of the adult-onset leukoencephalopathy in Taiwan. CSF1R mutations outside the tyrosine kinase domain may also disturb the CSF1R function and lead to the clinical phenotype. Molecular functional validation is important to determine the pathogenicity of novel CSF1R variants.
集落刺激因子 1 受体基因(CSF1R)的突变被鉴定为成人发病遗传性脑白质病的病因。本研究旨在调查 CSF1R 突变在台湾成年发病脑白质病患者中的频率、临床特征和功能影响。
通过靶向重测序panel 对 149 名无亲缘关系的脑白质病患者进行 CSF1R 突变分析,该 panel 覆盖了 CSF1R 的整个编码区域。对 CSF1R 突变蛋白的 CSF1 诱导的自身磷酸化活性进行体外分析,以评估 CSF1R 突变的致病性。
在本研究中鉴定出的 8 种 CSF1R 变体中,有 5 种突变导致 CSF1R 蛋白的 CSF1 诱导自身磷酸化丧失。四种突变(p.K586*、p.G589R、p.R777Q 和 p.R782C)位于 CSF1R 的酪氨酸激酶结构域内,而 p.T79M 突变位于免疫球蛋白样结构域。携带 CSF1R 突变的五名患者分别在 41、43、50、79 和 86 岁时出现认知能力下降。五名患者中有四名出现精神症状和行为改变。在早期阶段,执行功能和处理速度严重受损,他们的认知功能在 3-4 年内迅速恶化。三名患者发现皮质下区域和双侧皮质脊髓束弥散受限病变。
CSF1R 突变占台湾成年发病脑白质病的 3.5%(5/149)。酪氨酸激酶结构域外的 CSF1R 突变也可能干扰 CSF1R 功能并导致临床表型。分子功能验证对于确定新型 CSF1R 变体的致病性非常重要。